American International Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-231,933
| Closed | -$180M | – | 1498 |
|
|
2024
Q1 | $180M | Sell |
231,933
-3,145
| -1% | -$2.24M | 0.65% | 12 |
|
|
2023
Q4 | $137M | Sell |
235,078
-5,020
| -2% | -$2.93M | 0.56% | 13 |
|
|
2023
Q3 | $129M | Sell |
240,098
-1,791
| -0.7% | -$923K | 0.84% | 10 |
|
|
2023
Q2 | $113M | Buy |
241,889
+3,112
| +1% | +$1.31M | 0.69% | 15 |
|
|
2023
Q1 | $82M | Buy |
238,777
+1,039
| +0.4% | +$350K | 0.54% | 20 |
|
|
2022
Q4 | $87M | Sell |
237,738
-3,381
| -1% | -$1.2M | 0.61% | 19 |
|
|
2022
Q3 | $78M | Sell |
241,119
-5,431
| -2% | -$1.72M | 0.57% | 18 |
|
|
2022
Q2 | $79.9M | Sell |
246,550
-7,408
| -3% | -$2.22M | 0.54% | 20 |
|
|
2022
Q1 | $72.7M | Sell |
253,958
-6,055
| -2% | -$1.56M | 0.4% | 29 |
|
|
2021
Q4 | $71.8M | Buy |
260,013
+2,748
| +1% | +$697K | 0.36% | 39 |
|
|
2021
Q3 | $59.4M | Sell |
257,265
-4,087
| -2% | -$1.01M | 0.32% | 41 |
|
|
2021
Q2 | $60K | Buy |
261,352
+20,994
| +9% | +$4.22M | 0.2% | 89 |
|
|
2021
Q1 | $44.9K | Sell |
240,358
-7,156
| -3% | -$1.4M | 0.16% | 104 |
|
|
2020
Q4 | $41.8K | Sell |
247,514
-3,973
| -2% | -$593K | 0.15% | 99 |
|
|
2020
Q3 | $37.2M | Sell |
251,487
-26,599
| -10% | -$4.12M | 0.18% | 82 |
|
|
2020
Q2 | $45.7M | Buy |
278,086
+1,139
| +0.4% | +$175K | 0.22% | 68 |
|
|
2020
Q1 | $38.4M | Buy |
276,947
+510
| +0.2% | +$70.1K | 0.21% | 69 |
|
|
2019
Q4 | $36.3M | Buy |
276,437
+7,972
| +3% | +$924K | 0.14% | 88 |
|
|
2019
Q3 | $30M | Sell |
268,465
-6,674
| -2% | -$743K | 0.12% | 96 |
|
|
2019
Q2 | $30.5M | Sell |
275,139
-5,440
| -2% | -$641K | 0.12% | 90 |
|
|
2019
Q1 | $36.4M | Sell |
280,579
-28,226
| -9% | -$3.43M | 0.14% | 81 |
|
|
2018
Q4 | $35.7M | Sell |
308,805
-11,424
| -4% | -$1.28M | 0.15% | 76 |
|
|
2018
Q3 | $34.4M | Buy |
320,229
+20,925
| +7% | +$2.09M | 0.11% | 87 |
|
|
2018
Q2 | $25.5M | Sell |
299,304
-3,869
| -1% | -$318K | 0.09% | 102 |
|
|
2018
Q1 | $23.5M | Sell |
303,173
-1,817
| -0.6% | -$146K | 0.08% | 114 |
|
|
2017
Q4 | $25.8M | Buy |
304,990
+16,120
| +6% | +$1.37M | 0.08% | 104 |
|
|
2017
Q3 | $24.7M | Sell |
288,870
-26,473
| -8% | -$2.17M | 0.09% | 100 |
|
|
2017
Q2 | $26M | Buy |
315,343
+2,724
| +0.9% | +$222K | 0.09% | 100 |
|
|
2017
Q1 | $26.3M | Sell |
312,619
-461
| -0.1% | -$36.9K | 0.1% | 96 |
|
|
2016
Q4 | $23M | Buy |
313,080
+45
| +0% | +$3.35K | 0.09% | 100 |
|
|
2016
Q3 | $25.1M | Sell |
313,035
-350
| -0.1% | -$28K | 0.1% | 93 |
|
|
2016
Q2 | $24.7M | Sell |
313,385
-25,181
| -7% | -$1.9M | 0.1% | 96 |
|
|
2016
Q1 | $24.4M | Sell |
338,566
-11,505
| -3% | -$871K | 0.1% | 105 |
|
|
2015
Q4 | $29.5M | Buy |
350,071
+10,995
| +3% | +$912K | 0.12% | 96 |
|
|
2015
Q3 | $28.4M | Sell |
339,076
-22,591
| -6% | -$1.91M | 0.12% | 91 |
|
|
2015
Q2 | $30.2M | Sell |
361,667
-9,031
| -2% | -$688K | 0.12% | 94 |
|
|
2015
Q1 | $26.9M | Sell |
370,698
-128,082
| -26% | -$9.12M | 0.11% | 104 |
|
|
2014
Q4 | $34.4M | Sell |
498,780
-5,527,589
| -92% | -$373M | 0.15% | 71 |
|
|
2014
Q3 | $391M | Sell |
6,026,369
-63,625
| -1% | -$4.03M | 1.72% | 4 |
|
|
2014
Q2 | $379M | Buy |
6,089,994
+338,881
| +6% | +$20.2M | 1.67% | 6 |
|
|
2014
Q1 | $339M | Buy |
5,751,113
+286,339
| +5% | +$16M | 1.59% | 8 |
|
|
2013
Q4 | $279M | Buy |
5,464,774
+5,074,894
| +1,302% | +$254M | 1.34% | 21 |
|
|
2013
Q3 | $19.6M | Buy |
389,880
+6,593
| +2% | +$345K | 0.11% | 113 |
|
|
2013
Q2 | $18.8M | Buy |
+383,287
| New | +$20.9M | 0.11% | 114 |
|
Other funds holding LLY
American International Group's LLY Position: Q2 2024 in Review
American International Group sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 231,933 shares — an estimated $180M sold.
American International Group first reported a position in LLY in Q2 2013 and held it in 44 quarters. The position peaked at $391M in Q3 2014. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.
- American International Group reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
- American International Group sold 231,933 Eli Lilly shares in Q2 2024, an estimated $180M.
- American International Group first reported a position in Eli Lilly in Q2 2013 and held it in 44 quarters.
- American International Group's Eli Lilly position peaked at $391M in Q3 2014.
- 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.